von Overbeck J - Search Results

1

Survival in HIV infection: do sex and category of transmission matter? Swiss HIV Cohort Study.

von Overbeck J, Egger M, Smith GD, Schoep M, Ledergerber B, Furrer H, Malinverni R. von Overbeck J, et al. AIDS. 1994 Sep;8(9):1307-13. doi: 10.1097/00002030-199409000-00014. AIDS. 1994. PMID: 7802985

2

Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population.

Jaggy C, von Overbeck J, Ledergerber B, Schwarz C, Egger M, Rickenbach M, Furrer HJ, Telenti A, Battegay M, Flepp M, Vernazza P, Bernasconi E, Hirschel B; Swiss HIV Cohort Study. Jaggy C, et al. Among authors: von overbeck j. Lancet. 2003 Sep 13;362(9387):877-8. doi: 10.1016/S0140-6736(03)14307-3. Lancet. 2003. PMID: 13678976

3

Association of syncytium-inducing phenotype of HIV-1 with CD4 cell count, viral load and sociodemographic characteristics.

Furrer H, Wendland T, Minder C, Christen A, von Overbeck J, Grunow R, Pichler W, Malinverni RP. Furrer H, et al. Among authors: von overbeck j. AIDS. 1998 Jul 30;12(11):1341-6. doi: 10.1097/00002030-199811000-00016. AIDS. 1998. PMID: 9708414

4

The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics.

Ledergerber B, von Overbeck J, Egger M, Lüthy R. Ledergerber B, et al. Among authors: von overbeck j. Soz Praventivmed. 1994;39(6):387-94. doi: 10.1007/BF01299670. Soz Praventivmed. 1994. PMID: 7817627 Clinical Trial.

5

Foscarnet decreases human immunodeficiency virus RNA.

Kaiser L, Perrin L, Hirschel B, Furrer H, Von Overbeck J, Olmari M, Yerly S. Kaiser L, et al. Among authors: von overbeck j. J Infect Dis. 1995 Jul;172(1):225-7. doi: 10.1093/infdis/172.1.225. J Infect Dis. 1995. PMID: 7797916 Clinical Trial.

6

Inhibition of syncytia-inducing (SI) virus by autologous serum from HIV-1-infected individuals.

Grunow R, von Overbeck J, Frutig K, Frei E, Germann D, Furrer H, Perrin L, Pichler WJ. Grunow R, et al. Among authors: von overbeck j. Clin Diagn Virol. 1996 Aug;6(2-3):127-35. doi: 10.1016/0928-0197(96)00241-3. Clin Diagn Virol. 1996. PMID: 15566899

7

Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study.

Lorenzi P, Yerly S, Abderrakim K, Fathi M, Rutschmann OT, von Overbeck J, Leduc D, Perrin L, Hirschel B. Lorenzi P, et al. Among authors: von overbeck j. AIDS. 1997 Oct;11(12):F95-9. doi: 10.1097/00002030-199712000-00002. AIDS. 1997. PMID: 9342060 Clinical Trial.

8

[Epidemiology of HIV-1 infection in Bern--application of molecular methods].

Deiss V, von Overbeck J, Furrer HJ, Germann D, Matter L, Telenti A. Deiss V, et al. Among authors: von overbeck j. Schweiz Med Wochenschr. 1994 Apr 2;124(13):539-44. Schweiz Med Wochenschr. 1994. PMID: 8171305 German.

9

Reasons for failure of prevention of Toxoplasma encephalitis. Swiss HIV Cohort Study.

Van Delden C, Gabriel V, Sudre P, Flepp M, von Overbeck J, Hirschel B. Van Delden C, et al. Among authors: von overbeck j. AIDS. 1996 May;10(5):509-13. doi: 10.1097/00002030-199605000-00009. AIDS. 1996. PMID: 8724042

10

[Disseminated nontuberculous mycobacterial infections in AIDS patients].

Furrer H, Bodmer T, von Overbeck J. Furrer H, et al. Among authors: von overbeck j. Schweiz Med Wochenschr. 1994 Jan 22;124(3):89-96. Schweiz Med Wochenschr. 1994. PMID: 8115842 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters